Actual antihistamine therapy
Open Access
- 14 November 2020
- journal article
- research article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 16,p. 26-35
Abstract
The significance of the issues of allergic diseases is not in doubt. It is difficult to find a person who has not suffered at least some Allergy symptom, not everyone develops diseases, but most people face Allergy symptoms. The prevalence of various allergic diseases is increasing every year, currently reaching 30% of the population, and the world health organization predicts it will reach 50% in the next few decades. The most common nosologies are allergic rhinitis, bronchial asthma, atopic dermatitis, urticaria, but there are many other conditions of hypersensitivity. This article addresses the issues of inflammatory reactions in General and specifically allergic inflammation, discusses the main aspects of the pathogenesis of allergic rhinitis and urticaria, and questions of drug therapy for these diseases. Most people are sure that they can take anti-allergic medications for allergies, and most often they are referring to antihistamines. Unfortunately, even some medical specialists lack an understanding of the specifics of antihistamine therapy. some people still believe that there are three or four generations of antihistamines, and patients use drugs not as prescribed by doctors, but on the recommendation of friends or pharmacists. Irrational use of antihistamines leads to a decrease in effectiveness, and it is not uncommon to discredit specific drugs and groups of drugs in General. This article demonstrates the results of various European and Asian studies on the effectiveness and safety of antihistamines and bilastin in particular, as well as their own experience of using antihistamines in practice.Keywords
This publication has 33 references indexed in Scilit:
- Up‐dosing with bilastine results in improved effectiveness in cold contact urticariaAllergy, 2013
- Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence reviewCurrent Medical Research and Opinion, 2011
- Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled studyAllergy, 2010
- Prevalence of immunoglobulin E‐mediated food allergy in 6–9‐year‐old urban schoolchildren in the eastern Black Sea region of TurkeyClinical & Experimental Allergy, 2009
- The diagnosis and management of rhinitis: An updated practice parameterJournal of Allergy and Clinical Immunology, 2008
- Acquired cold urticaria: clinical picture and update on diagnosis and treatmentClinical and Experimental Dermatology, 2007
- EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticariaAllergy, 2006
- Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003Journal of Allergy and Clinical Immunology, 2004
- A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit – the Vienna Challenge Chamber (VCC)Current Medical Research and Opinion, 2004
- A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task forceAllergy, 2001